M&T Bank’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$928K Buy
20,872
+9,232
+79% +$332K ﹤0.01% 927
2026
Q1
$374K Buy
11,640
+2,938
+34% +$104K ﹤0.01% 1267
2025
Q4
$313K Buy
8,702
+1,279
+17% +$47K ﹤0.01% 1378
2025
Q3
$233K Buy
+7,423
New +$267K ﹤0.01% 1323
2023
Q3
Sell
-6,108
Closed -$229K 1671
2023
Q2
$229K Buy
+6,108
New +$201K ﹤0.01% 1417
2023
Q1
Sell
-7,887
Closed -$208K 1750
2022
Q4
$208K Buy
+7,887
New +$188K ﹤0.01% 1463

Other funds holding VCEL

M&T Bank's VCEL Position: Q2 2026 in Review

M&T Bank increased its Vericel Corp (VCEL) stake by 79% in Q2 2026, buying an estimated $332K and bringing the position to 20,872 shares worth $928K. The position accounts for ﹤0.01% of the portfolio, ranked #927.

M&T Bank first reported a position in VCEL in Q4 2022 and has held it in 6 quarters since. 320 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

  • M&T Bank held 20,872 shares of Vericel Corp worth $928K as of Q2 2026.
  • M&T Bank bought 9,232 Vericel Corp shares in Q2 2026, an estimated $332K.
  • Vericel Corp made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #927 holding.
  • M&T Bank first reported a position in Vericel Corp in Q4 2022 and has held it in 6 quarters since.
  • 320 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.